De Pablo-Fernandez, E;
Gebeyehu, GG;
Flain, L;
Slater, R;
Frau, A;
Ijaz, UZ;
Warner, T;
(2022)
The faecal metabolome and mycobiome in Parkinson's disease.
Parkinsonism & Related Disorders
, 95
pp. 65-69.
10.1016/j.parkreldis.2022.01.005.
Preview |
Text
De Pablo Fernandez_The faecal metabolome and mycobiome in Parkinson's disease_AAM.pdf - Accepted Version Download (110kB) | Preview |
Preview |
Text
Supplementary material_R1_Final.pdf - Accepted Version Download (654kB) | Preview |
Preview |
Image
Figure 1.tif - Accepted Version Download (130MB) | Preview |
Abstract
BACKGROUND: Gut fungal composition and its metabolites have not been assessed simultaneously in Parkinson's disease (PD) despite their potential pathogenic contribution. OBJECTIVE: To evaluate the faecal metabolome and mycobiome in PD by assessing volatile organic compounds (VOCs) and fungal rRNA. METHODS: Faecal VOCs from 35 PD patients and two control groups (n = 35; n = 15) were assessed using gas chromatography and mass spectrometry. DNA was extracted from 44 samples: 18S rRNA gene amplicons were prepared and sequenced. Metabolomics, mycobiome and integrated analyses were performed. RESULTS: Several VOCs were more abundant and short chain fatty acids were less abundant in PD. Hanseniaspora, Kazachstania, uncultured Tremellaceae and Penicillium genera were more abundant, and Saccharomyces less abundant in PD (FDR<0.0007). Torulaspora was associated with PD and two VOCs. CONCLUSION: PD patients had a distinct metabolome and mycobiome suggesting that fungal dysbiosis may contribute to PD pathogenesis.
Archive Staff Only
 |
View Item |
